Global Medical REIT Inc.(GMRE)Earnings, Financials & Key Ratios
GMRE•NYSE•REIT / Real Estate
$35.74
$94M mkt cap·115.3× P/E·Price updated Apr 24, 2026
AboutGlobal Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.Show more
- Revenue$138M-1.8%
- FFO$63M-21.2%
- FFO/Share23.78-21.7%
- FFO Payout95.46%+28.8%
- FFO per Share23.78-21.7%
- NOI Margin78.87%-1.5%
- FFO Margin45.31%-19.8%
- ROE1.14%-65.2%
- ROA0.53%-66.1%
- Debt/Assets52.02%+5.6%
- Net Debt/EBITDA7.29+13.3%
- Book Value/Share210.78-8.8%
GMRE Key Insights
Global Medical REIT Inc. (GMRE) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High NOI margin of 78.9%
- ✓Trading at only 0.2x book value
✗Weaknesses
- ✗Weak 3Y average ROE of 2.5%
- ✗Dividend payout exceeds 100% of earnings
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
GMRE Price & Volume
Global Medical REIT Inc. (GMRE) stock price & volume — 10-year historical chart
Loading chart...
GMRE Growth Metrics
Global Medical REIT Inc. (GMRE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years80.34%
5 Years14.37%
3 Years6.12%
TTM8.51%
Profit CAGR
10 Years-
5 Years-6.4%
3 Years-27.8%
TTM-43.47%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-51%
Return on Capital
10 Years3.69%
5 Years5.08%
3 Years5.39%
Last Year5.3%
GMRE Recent Earnings
Global Medical REIT Inc. (GMRE) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 3/12 qtrs (25%)●Beat Revenue 8/12 qtrs (67%)
Q4 2025Latest
Nov 4, 2025EPS
$1.12
Est $1.05
+6.7%
Revenue
$41M
Est $37M
+8.3%
Q3 2025
Aug 5, 2025EPS
$1.15
Est $1.15
+0.0%
Revenue
$41M
Est $36M
+14.7%
Q2 2025
May 7, 2025EPS
$0.22
Est $0.22
+0.0%
Revenue
$35M
Est $35M
-2.4%
Q1 2025
Feb 27, 2025EPS
$0.22
Est $0.01
+2100.0%
Revenue
$35M
Est $35M
+0.2%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q4 2025Latest | Nov 4, 2025 | $1.12vs $1.05+6.7% | $41Mvs $37M+8.3% |
| Q3 2025 | Aug 5, 2025 | $1.15vs $1.15+0.0% | $41Mvs $36M+14.7% |
| Q2 2025 | May 7, 2025 | $0.22vs $0.22+0.0% | $35Mvs $35M-2.4% |
| Q1 2025 | Feb 27, 2025 | $0.22vs $0.01+2100.0% | $35Mvs $35M+0.2% |
Based on last 12 quarters of dataView full earnings history →
GMRE Peer Comparison
Global Medical REIT Inc. (GMRE) competitors in Outpatient medical offices and clinics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CHCT | 504.01M | 17.64 | 227.91 | 4.67% | 4.96% | 1.41% | 11.2% | 1.25 |
 NXRT | 748.15M | 29.48 | -23.40 | -3.24% | -12.67% | -10.13% | 11.17% | 5.18 |
 PLYM | 979.23M | 21.98 | 7.11 | -0.75% | 48.46% | 16.78% | 9.81% | 1.10 |
 HR | 6.95B | 19.92 | -28.06 | -6.92% | -17.51% | -4.28% | 1.83% | 0.89 |
 DOC | 11.48B | 16.51 | 165.10 | 4.52% | 7.73% | 2.6% | 9.99% | 1.26 |
 MPW | 3.37B | 5.65 | -17.12 | -2.36% | -20.44% | -4.31% | 6.84% | 0.03 |
 OHI | 13.73B | 46.12 | 23.77 | 13.95% | 51.02% | 11.85% | 6.4% | 0.78 |
 SBRA | 5.14B | 20.38 | 31.84 | 10.15% | 19.21% | 5.6% | 6.78% | 0.90 |
Compare GMRE vs Peers
Global Medical REIT Inc. (GMRE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GMRE Income Statement
Global Medical REIT Inc. (GMRE) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.08M | 30.22M | 53.19M | 70.73M | 93.52M | 115.8M | 137.17M | 140.93M | 138.41M | 147.99M |
| Revenue Growth % | 291.89% | 274.07% | 76% | 32.96% | 32.23% | 23.83% | 18.45% | 2.75% | -1.79% | 8.51% |
| Property Operating Expenses | 1.43M | 1.86M | 3.72M | 6.54M | 10.87M | 15.49M | 25.19M | 28.08M | 29.25M | 46.23M |
| Net Operating Income (NOI) | 6.65M▲ 0% | 28.36M▲ 326.8% | 49.47M▲ 74.4% | 64.19M▲ 29.7% | 82.65M▲ 28.8% | 100.32M▲ 21.4% | 111.98M▲ 11.6% | 112.85M▲ 0.8% | 109.16M▼ 3.3% | 101.76M▲ 0% |
| NOI Margin % | 82.25% | 93.85% | 93.01% | 90.76% | 88.38% | 86.63% | 81.64% | 80.07% | 78.87% | 68.76% |
| Operating Expenses | 8.1M | 18.61M | 27.23M | 14.25M | 82.65M | 63.33M | 73.27M | 74.99M | 76.48M | 64.97M |
| G&A Expenses | 5.73M | 8.61M | 9.96M | 14.25M | 29.96M | 16.45M | 16.55M | 16.85M | 21.12M | 22.21M |
| EBITDA | 8.21M | 30.34M | 53.58M | 73.7M | 53M | 84.3M | 96.37M | 96.87M | 88.76M | 95.03M |
| EBITDA Margin % | 101.62% | 100.4% | 100.72% | 104.21% | 56.67% | 72.79% | 70.26% | 68.74% | 64.13% | 64.22% |
| Depreciation & Amortization | 10.43M | 23M | 31.33M | 23.76M | 36.82M | 47.31M | 57.66M | 59.01M | 56.08M | 58.24M |
| D&A / Revenue % | 129.03% | 76.09% | 58.9% | 33.6% | 39.37% | 40.85% | 42.04% | 41.87% | 40.52% | 39.35% |
| Operating Income | -2.21M▲ 0% | 7.35M▲ 431.8% | 22.24M▲ 202.7% | 49.94M▲ 124.5% | 0▼ 100.0% | 36.99M▲ 0% | 38.71M▲ 4.7% | 37.86M▼ 2.2% | 32.68M▼ 13.7% | 36.79M▲ 0% |
| Operating Margin % | -27.41% | 24.31% | 41.82% | 70.61% | 0% | 31.94% | 28.22% | 26.87% | 23.61% | 24.86% |
| Interest Expense | 4.14M | 7.43M | 14.97M | 17.47M | 18.68M | 19.7M | 25.23M | 30.89M | 28.69M | 4M |
| Interest Coverage | -0.54x | 0.99x | 1.49x | 2.86x | - | 1.88x | 1.53x | 1.23x | 1.14x | - |
| Non-Operating Income | 2.19M | 2.52M | -7.29M | 22.88M | -16.18M | -1.05M | -6.51M | -14.76M | -2.7M | 11.84M |
| Pretax Income | -6.35M▲ 0% | -87K▲ 98.6% | 14.56M▲ 16836.8% | 9.59M▼ 34.2% | -2.5M▼ 126.1% | 18.34M▲ 834.0% | 20M▲ 9.0% | 21.73M▲ 8.7% | 6.69M▼ 69.2% | 2.2M▲ 0% |
| Pretax Margin % | -78.64% | -0.29% | 27.37% | 13.56% | -2.67% | 15.84% | 14.58% | 15.42% | 4.83% | 1.49% |
| Income Tax | 4.27M | -49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -67.21% | 56.32% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -6.35M▲ 0% | -38K▲ 99.4% | 13.49M▲ 35600.0% | 9.23M▼ 31.5% | -1.93M▼ 120.8% | 17.62M▲ 1015.4% | 19.14M▲ 8.6% | 20.61M▲ 7.7% | 6.63M▼ 67.8% | 2.5M▲ 0% |
| Net Margin % | -78.64% | -0.13% | 25.36% | 13.06% | -2.06% | 15.22% | 13.96% | 14.63% | 4.79% | 1.69% |
| Net Income Growth % | -294.81% | 99.4% | 35600% | -31.55% | -120.85% | 1015.43% | 8.63% | 7.68% | -67.82% | -43.47% |
| Funds From Operations (FFO) | 4.07M▲ 0% | 22.96M▲ 463.8% | 44.82M▲ 95.2% | 32.99M▼ 26.4% | 34.89M▲ 5.8% | 64.93M▲ 86.1% | 76.8M▲ 18.3% | 79.62M▲ 3.7% | 62.72M▼ 21.2% | 60.74M▲ 0% |
| FFO Margin % | 50.4% | 75.96% | 84.26% | 46.65% | 37.31% | 56.07% | 55.99% | 56.5% | 45.31% | 41.04% |
| FFO Growth % | 528.79% | 463.84% | 95.23% | -26.38% | 5.75% | 86.08% | 18.29% | 3.67% | -21.23% | 7.49% |
| FFO per Share | 10.94 | 29.26 | 51.00 | 24.36 | 18.86 | 26.77 | 29.33 | 30.37 | 23.78 | 4.54 |
| FFO Payout Ratio % | 95.24% | 66.34% | 42.31% | 88.41% | 114.48% | 80.86% | 76.06% | 74.13% | 95.46% | 88.23% |
| EPS (Diluted) | -17.00▲ 0% | -0.05▲ 99.7% | 15.25▲ 32205.3% | -6.00▼ 139.3% | -11.25▼ 87.5% | -0.86▲ 92.4% | -2.00▼ 133.9% | 5.75▲ 387.5% | 0.31▼ 94.6% | 0.19▲ 0% |
| EPS Growth % | 89.44% | 99.72% | 32205.26% | -139.34% | -87.5% | 92.4% | -133.92% | 387.5% | -94.61% | -51% |
| EPS (Basic) | -17.00 | -0.05 | 15.25 | -6.00 | -11.25 | -0.86 | -2.00 | 5.75 | 0.31 | - |
| Diluted Shares Outstanding | 372.08K | 784.68K | 878.84K | 1.35M | 1.85M | 2.43M | 2.62M | 2.62M | 2.64M | 13.38M |
GMRE Balance Sheet
Global Medical REIT Inc. (GMRE) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 227.32M | 474.57M | 636.1M | 884.93M | 1.1B | 1.26B | 1.39B | 1.27B | 1.26B | 1.27B |
| Asset Growth % | 247.96% | 108.77% | 34.04% | 39.12% | 24.41% | 14.77% | 10.27% | -9.01% | -0.88% | 6.55% |
| Real Estate & Other Assets | 1.77M | 7.2M | 589.99M | 18.19M | 21.98M | 1.14B | 1.26B | 1.17B | 1.17B | 1.18B |
| PP&E (Net) | 196.37M | 426.26M | 139K | 792.98M | 978.71M | 3.81M | 5.03M | 10.97M | 7.27M | 18.12M |
| Investment Securities | -1000K | -1000K | -1000K | 0 | 0 | 0 | 0 | 0 | 1000K | 1000K |
| Total Current Assets | 22.04M | 9.46M | 9.68M | 32.3M | 42.05M | 24.95M | 30.53M | 14.35M | 17.35M | 18.7M |
| Cash & Equivalents | 19.67M | 5.11M | 3.63M | 2.77M | 5.51M | 7.21M | 4.02M | 1.28M | 6.82M | 7.12M |
| Receivables | 212.44K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 3.64M | 2.96M | 10.37M | 10.75M | 11.5M | 18.27M | 6.12M | 2.84M | 3.27M |
| Intangible Assets | 7.14M | 31.65M | 36.29M | 41.46M | 52.27M | 87.94M | 91.31M | 65.97M | 54.07M | 50.53M |
| Total Liabilities | 72.29M | 215.56M | 336.35M | 424.58M | 643.15M | 625.91M | 744.2M | 661.89M | 700.57M | 767.41M |
| Total Debt | 66.53M | 203.44M | 315.01M | 395.06M | 607.62M | 579.86M | 704.65M | 624.19M | 653.59M | 728.66M |
| Net Debt | 46.86M | 198.34M | 311.38M | 392.3M | 602.11M | 572.64M | 700.64M | 622.91M | 646.78M | 721.53M |
| Long-Term Debt | 66.11M | 200.69M | 315.01M | 386.17M | 586.58M | 57.16M | 57.67M | 25.9M | 14.4M | 709.63M |
| Short-Term Borrowings | 27.7M | 0 | 276.35M | 6.49M | 18.09M | 514.57M | 636.45M | 585.33M | 631.73M | 0 |
| Capital Lease Obligations | 277.92K | 1.29M | 2.03M | 2.4M | 2.96M | 8.13M | 10.54M | 12.96M | 7.46M | 59.16M |
| Total Current Liabilities | 32.46M | 173.59M | 288.03M | 24.84M | 37.84M | 540.58M | 670.53M | 619.34M | 671.45M | 35.24M |
| Accounts Payable | 574K | 2.02M | 3.66M | 5.07M | 7.28M | 10.34M | 13.82M | 12.78M | 16.47M | 17.81M |
| Deferred Revenue | 3.19M | 212.81M | 336.35M | 0 | 0 | 0 | 4.44M | 5.09M | 6.73M | 5.38M |
| Other Liabilities | -26.56M | 3.16M | 5.18M | 11.16M | 15.78M | 20.04M | 5.46M | 3.69M | 7.26M | 3.51M |
| Total Equity | 200.02M▲ 0% | 259.01M▲ 29.5% | 299.75M▲ 15.7% | 460.35M▲ 53.6% | 457.76M▼ 0.6% | 637.58M▲ 39.3% | 649.07M▲ 1.8% | 605.81M▼ 6.7% | 555.92M▼ 8.2% | 505.83M▲ 0% |
| Equity Growth % | 144403.32% | 29.5% | 15.73% | 53.58% | -0.56% | 39.28% | 1.8% | -6.66% | -8.24% | -37.75% |
| Shareholders Equity | 155.03M | 246.34M | 269.3M | 430.27M | 444.81M | 622.78M | 632.98M | 583.58M | 534.13M | 485.29M |
| Minority Interest | 44.99M | 12.68M | 30.45M | 30.08M | 12.96M | 14.79M | 16.08M | 22.23M | 21.79M | 20.54M |
| Common Stock | 17.61K | 22K | 26K | 44K | 49K | 65K | 66K | 66K | 67K | 13K |
| Additional Paid-in Capital | 172M | 205.79M | 243.04M | 433.33M | 504.79M | 711.41M | 721.99M | 722.42M | 734.22M | 735.42M |
| Retained Earnings | -16.99M | -34.43M | -45.01M | -71.39M | -116.77M | -157.02M | -198.71M | -238.98M | -293.74M | -332.57M |
| Preferred Stock | 0 | 74.96M | 74.96M | 74.96M | 74.96M | 74.96M | 74.96M | 74.96M | 74.96M | 74.96M |
| Return on Assets (ROA) | -4.34% | -0.01% | 2.43% | 1.21% | -0.19% | 1.49% | 1.44% | 1.55% | 0.53% | 0.2% |
| Return on Equity (ROE) | -6.36% | -0.02% | 4.83% | 2.43% | -0.42% | 3.22% | 2.98% | 3.29% | 1.14% | 0.49% |
| Debt / Assets | 29.27% | 42.87% | 49.52% | 44.64% | 55.19% | 45.89% | 50.58% | 49.24% | 52.02% | 57.23% |
| Debt / Equity | 0.33x | 0.79x | 1.05x | 0.86x | 1.33x | 0.91x | 1.09x | 1.03x | 1.18x | 1.18x |
| Net Debt / EBITDA | 5.71x | 6.54x | 5.81x | 5.32x | 11.36x | 6.79x | 7.27x | 6.43x | 7.29x | 7.29x |
| Book Value per Share | 537.56 | 330.09 | 341.07 | 339.84 | 247.41 | 262.85 | 247.88 | 231.05 | 210.78 | 37.80 |
GMRE Cash Flow Statement
Global Medical REIT Inc. (GMRE) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -2.72M | 11.6M | 24.83M | 36.43M | 34.52M | 68.97M | 76.54M | 68.44M | 70.05M | 70.05M |
| Operating CF Growth % | -1204.19% | 526.08% | 114.03% | 46.68% | -5.24% | 99.79% | 10.98% | -10.58% | 2.35% | 23.81% |
| Operating CF / Revenue % | -33.7% | 38.39% | 46.69% | 51.5% | 36.91% | 59.55% | 55.8% | 48.56% | 50.61% | 47.33% |
| Net Income | -6.35M | -87K | 14.56M | 9.59M | -2.5M | 18.34M | 20M | 20.61M | 6.63M | 2.5M |
| Depreciation & Amortization | 2.38M | 10.13M | 17.96M | 25.52M | 36.82M | 47.31M | 57.66M | 59.01M | 56.08M | 56.85M |
| Stock-Based Compensation | 1.68M | 1.8M | 2.67M | 3.34M | 5.32M | 5.81M | 4.68M | 4.24M | 5.1M | 4.36M |
| Other Non-Cash Items | 350.44K | 1.48M | 1.75M | 1.76M | 1.56M | 1.33M | -4.06M | -9.73M | 1.01M | 4.17M |
| Working Capital Changes | -780.96K | -1.71M | -4.43M | -3.77M | -7.65M | -3.82M | -1.74M | -5.69M | 1.21M | 5.09M |
| Cash from Investing | -150.36M | -252.65M | -151.62M | -258.2M | -223.67M | -194.66M | -137.25M | 67.62M | -45.94M | -86.67M |
| Acquisitions (Net) | -140.37K | 0 | 0 | 0 | -5.09M | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | -797.82K | -426K | -373K | 0 | -1.54M | 0 | 0 | 0 | 0 | 204K |
| Sale of Investments | 242.04K | 21K | 1000K | 0 | 208K | 0 | 0 | 0 | 1000K | 2M |
| Other Investing | 242.04K | -433K | 5.26M | -3.21M | 1.54M | -2.41M | 13.68M | 67.62M | -103.56M | -80.52M |
| Cash from Financing | 163.57M | 226.49M | 124.51M | 224.11M | 192.72M | 127.7M | 62.41M | -143.79M | -21.89M | 16.23M |
| Dividends Paid | -3.88M | -15.98M | -24.79M | -34.99M | -45.77M | -58.32M | -64.24M | -64.85M | -65.69M | -57.96M |
| Common Dividends | -3.88M | -15.23M | -18.96M | -29.17M | -39.94M | -52.5M | -58.42M | -59.02M | -59.87M | -53.59M |
| Debt Issuance (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K | -1000K | 1000K | 2M |
| Share Repurchases | 0 | 0 | -263K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -2.9M | -3.06M | -3.1M | -1.33M | -2.83M | -8.89M | -5.19M | 7.15M | 252K | -4.34M |
| Net Change in Cash | 10.49M▲ 0% | -14.56M▼ 238.9% | -2.27M▲ 84.4% | 2.34M▲ 203.1% | 3.57M▲ 52.3% | 2.01M▼ 43.8% | 1.7M▼ 15.5% | -7.73M▼ 555.8% | 2.22M▲ 128.7% | 2.05M▲ 0% |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 9.18M | 19.67M | 7.11M | 4.84M | 7.18M | 10.75M | 12.76M | 14.46M | 6.72M | 9.23M |
| Cash at End | 19.67M | 5.11M | 4.84M | 7.18M | 10.75M | 12.76M | 14.46M | 6.72M | 8.94M | 9.84M |
| Free Cash Flow | -153.18M▲ 0% | -240.62M▼ 57.1% | -156M▲ 35.2% | -220.38M▼ 41.3% | -184.27M▲ 16.4% | -132.69M▲ 28.0% | -79.66M▲ 40.0% | 58.39M▲ 173.3% | -25.07M▼ 142.9% | 18.63M▲ 0% |
| FCF Growth % | -372.6% | -57.08% | 35.17% | -41.27% | 16.39% | 27.99% | 39.97% | 173.3% | -142.94% | -70.81% |
| FCF / Revenue % | -1895.93% | -796.14% | -293.28% | -311.6% | -197.04% | -114.58% | -58.08% | 41.43% | -18.12% | 12.59% |
GMRE Key Ratios
Global Medical REIT Inc. (GMRE) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| FFO per Share | 10.94 | 29.26 | 51 | 24.36 | 18.86 | 26.77 | 29.33 | 30.37 | 23.78 | 4.54 |
| FFO Payout Ratio | 95.24% | 66.34% | 42.31% | 88.41% | 114.48% | 80.86% | 76.06% | 74.13% | 95.46% | 88.23% |
| NOI Margin | 82.25% | 93.85% | 93.01% | 90.76% | 88.38% | 86.63% | 81.64% | 80.07% | 78.87% | 68.76% |
| Net Debt / EBITDA | 5.71x | 6.54x | 5.81x | 5.32x | 11.36x | 6.79x | 7.27x | 6.43x | 7.29x | 7.29x |
| Debt / Assets | 29.27% | 42.87% | 49.52% | 44.64% | 55.19% | 45.89% | 50.58% | 49.24% | 52.02% | 57.23% |
| Interest Coverage | -0.54x | 0.99x | 1.49x | 2.86x | - | 1.88x | 1.53x | 1.23x | 1.14x | - |
| Book Value / Share | 537.56 | 330.09 | 341.07 | 339.84 | 247.41 | 262.85 | 247.88 | 231.05 | 210.78 | 37.8 |
| Revenue Growth | 291.89% | 274.07% | 76% | 32.96% | 32.23% | 23.83% | 18.45% | 2.75% | -1.79% | 8.51% |
GMRE Frequently Asked Questions
Global Medical REIT Inc. (GMRE) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Global Medical REIT Inc. (GMRE) reported $148.0M in revenue for fiscal year 2024.
Global Medical REIT Inc. (GMRE) saw revenue decline by 1.8% over the past year.
Yes, Global Medical REIT Inc. (GMRE) is profitable, generating $2.5M in net income for fiscal year 2024 (4.8% net margin).
Dividend & Returns
Yes, Global Medical REIT Inc. (GMRE) pays a dividend with a yield of 63.51%. This makes it attractive for income-focused investors.
Global Medical REIT Inc. (GMRE) has a return on equity (ROE) of 1.1%. This is below average, suggesting room for improvement.
Industry Metrics
Global Medical REIT Inc. (GMRE) generated Funds From Operations (FFO) of $60.7M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Global Medical REIT Inc. (GMRE) offers a 63.51% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.
Explore More GMRE
Global Medical REIT Inc. (GMRE) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates